Shree Ganesh Remedies Limited engages in the manufacture and sale of pharmaceutical drug intermediates for active pharmaceutical ingredient (API) and fine chemicals in India and internationally. The company offers anti-arrhythmic, anti-cancer, anti-depressant, anti-diabetic, anti-diarrheal, antifungal, antihistamine, anti-inflammatory, anti-parasitic, anti-psychotic, anticholinergic, birth-control, cardiovascular, gastrointestinal, neurological disorder, ophthalmic, opioid, and veterinary API intermediates. It also provides fine and specialty chemicals, such as agro-chemicals, electronics, flavor and fragrance, life-sciences, and polymer chemicals, as well as other specialty chemicals. In addition, the company offers customized chemistry development and manufacturing; assets and infrastructure; and customized processes of pharmaceutical chemicals. It also exports its products. The company serves life sciences, flavor and fragrance, polymer industries, electronics, and agro chemicals ma
| Current Price | ₹796.30 |
|---|---|
| Market Cap | ₹719 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 40.5 |
| Return on Equity | 11.53% |
| 52-Week Range | ₹557.95 – ₹950.05 |
| Beta (1Y) | 0.37 |
| Dividend Yield | 0.00% |
1. Bulk Drug Intermediates-100%
Shree Ganesh Remedies Ltd is trading at ₹796.30, with a market capitalisation of ₹719 Cr.
Shree Ganesh Remedies Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Medicinal Chemicals and Botanical Products).
Shree Ganesh Remedies Ltd has a P/E of 40.5 and a return on equity of 11.53%.